eli lilly weight loss drug news - Search News

US approves 1st drug treatment for sleep apnea

Hosted on MSN · 2d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

USA Today · 1d

Eli Lilly to test weight loss drug Zepbound to treat addiction

Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?

UPI News on MSN · 1d

FDA approves weight-loss drug Zepbound to treat sleep apnea

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.

8m

Does This News From the FDA Make Eli Lilly a Buy for 2025?

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

3don MSN

Lilly’s US Weight-Loss Drug Shortage Ends, Curtailing Copies

Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...

2don MSN

Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results